BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 33512081)

  • 1. No impact of soluble epoxide hydrolase rs4149243, rs2234914 and rs751142 genetic variants on the development of type II diabetes and its hypertensive complication among Jordanian patients.
    Khamees M; Jarrar Y; Al-Qirim T; Mahmoud IS; Hatmal MM; Alshaer W; Lee SJ
    Int J Clin Pract; 2021 May; 75(5):e14036. PubMed ID: 33512081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of
    Ma L; Yan M; Kong X; Jiang Y; Zhao T; Zhao H; Liu Q; Zhang H; Liu P; Cao Y; Li P
    J Diabetes Res; 2018; 2018():2786470. PubMed ID: 29629376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of rs11780592 Polymorphism in the Human Soluble Epoxide Hydrolase Gene (EPHX2) with Oxidized LDL and Mortality in Patients with Diabetic Chronic Kidney Disease.
    Roumeliotis S; Roumeliotis A; Stamou A; Panagoutsos S; Manolopoulos VG; Tsetsos F; Georgitsi M; Liakopoulos V
    Oxid Med Cell Longev; 2021; 2021():8817502. PubMed ID: 34040693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hypothesis-driven study to comprehensively investigate the association between genetic polymorphisms in EPHX2 gene and cardiovascular diseases: Findings from the UK Biobank.
    Zhu X; Li Y; Yu T; Li S; Chen M
    Gene; 2022 May; 822():146340. PubMed ID: 35183688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.
    Lee CR; North KE; Bray MS; Fornage M; Seubert JM; Newman JW; Hammock BD; Couper DJ; Heiss G; Zeldin DC
    Hum Mol Genet; 2006 May; 15(10):1640-9. PubMed ID: 16595607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Nudix Hydrolase 15 (NUDT15) Gene Variants among Jordanian Arab Population.
    Jarrar YB; Ghishan M
    Asian Pac J Cancer Prev; 2019 Mar; 20(3):801-808. PubMed ID: 30909691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study.
    Burdon KP; Lehtinen AB; Langefeld CD; Carr JJ; Rich SS; Freedman BI; Herrington D; Bowden DW
    Diab Vasc Dis Res; 2008 Jun; 5(2):128-34. PubMed ID: 18537101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered soluble epoxide hydrolase gene expression and function and vascular disease risk in the stroke-prone spontaneously hypertensive rat.
    Corenblum MJ; Wise VE; Georgi K; Hammock BD; Doris PA; Fornage M
    Hypertension; 2008 Feb; 51(2):567-73. PubMed ID: 18086949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome.
    Oni-Orisan A; Cresci S; Jones PG; Theken KN; Spertus JA; Lee CR
    Prostaglandins Other Lipid Mediat; 2018 Sep; 138():15-22. PubMed ID: 30096423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygosity for the EPHX2 K55R polymorphism increases the long-term risk of ischemic stroke in men: a study in Swedes.
    Fava C; Montagnana M; Danese E; Almgren P; Hedblad B; Engström G; Berglund G; Minuz P; Melander O
    Pharmacogenet Genomics; 2010 Feb; 20(2):94-103. PubMed ID: 20065888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arg287Gln variant of EPHX2 and epoxyeicosatrienoic acids are associated with insulin sensitivity in humans.
    Ramirez CE; Shuey MM; Milne GL; Gilbert K; Hui N; Yu C; Luther JM; Brown NJ
    Prostaglandins Other Lipid Mediat; 2014 Oct; 113-115():38-44. PubMed ID: 25173047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the role of EPHX2 gene variants in anorexia nervosa.
    Scott-Van Zeeland AA; Bloss CS; Tewhey R; Bansal V; Torkamani A; Libiger O; Duvvuri V; Wineinger N; Galvez L; Darst BF; Smith EN; Carson A; Pham P; Phillips T; Villarasa N; Tisch R; Zhang G; Levy S; Murray S; Chen W; Srinivasan S; Berenson G; Brandt H; Crawford S; Crow S; Fichter MM; Halmi KA; Johnson C; Kaplan AS; La Via M; Mitchell JE; Strober M; Rotondo A; Treasure J; Woodside DB; Bulik CM; Keel P; Klump KL; Lilenfeld L; Plotnicov K; Topol EJ; Shih PB; Magistretti P; Bergen AW; Berrettini W; Kaye W; Schork NJ
    Mol Psychiatry; 2014 Jun; 19(6):724-32. PubMed ID: 23999524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred.
    Sato K; Emi M; Ezura Y; Fujita Y; Takada D; Ishigami T; Umemura S; Xin Y; Wu LL; Larrinaga-Shum S; Stephenson SH; Hunt SC; Hopkins PN
    J Hum Genet; 2004; 49(1):29-34. PubMed ID: 14673705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the soluble epoxide hydrolase gene and preeclampsia.
    Sari I; Pinarbasi H; Pinarbasi E; Yildiz C
    Hypertens Pregnancy; 2017 Nov; 36(4):315-325. PubMed ID: 29058492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence analysis of the N-acetyltransferase 2 gene (NAT2) among Jordanian volunteers.
    Jarrar YB; Balasmeh AA; Jarrar W
    Libyan J Med; 2018 Dec; 13(1):1408381. PubMed ID: 29173142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between EPHX2 gene polymorphism and essential hypertension in Kazaks and Hans in Xinjiang].
    Li N; Wang L; Ding H; Wang Z; Wang DW; Xu YJ; Zhang WQ; Duan JC; Wang YH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Dec; 39(12):1101-4. PubMed ID: 22336502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke.
    Fornage M; Lee CR; Doris PA; Bray MS; Heiss G; Zeldin DC; Boerwinkle E
    Hum Mol Genet; 2005 Oct; 14(19):2829-37. PubMed ID: 16115816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frequency of cytochrome 4F2 rs2108622 genetic variant and its effects on the lipid profile and complications of type II diabetes among a sample of patients in Jordan: A pilot study.
    Jarrar Y; Alkhalili M; Alhawari H; Abaalkhail SJ; Alkhalili S; Alhawari H; Momani M; Obeidat AN; Fram RK
    Prostaglandins Other Lipid Mediat; 2023 Apr; 165():106715. PubMed ID: 36758722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between polymorphisms of CYP2J2 and EPHX2 genes and risk of coronary artery disease.
    Xu Y; Ding H; Peng J; Cui G; Liu L; Cianflone K; Wang DW
    Pharmacogenet Genomics; 2011 Aug; 21(8):489-94. PubMed ID: 21642892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants in KCNQ1 increase type II diabetes susceptibility in South Asians: a study of 3,310 subjects from India and the US.
    Been LF; Ralhan S; Wander GS; Mehra NK; Singh J; Mulvihill JJ; Aston CE; Sanghera DK
    BMC Med Genet; 2011 Jan; 12():18. PubMed ID: 21261977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.